203 related articles for article (PubMed ID: 31831297)
1. Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening.
Mamontova EM; Zakharenko AL; Zakharova OD; Dyrkheeva NS; Volcho KP; Reynisson J; Arabshahi HJ; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2020 Jan; 28(1):115234. PubMed ID: 31831297
[TBL] [Abstract][Full Text] [Related]
2. The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair Enzyme.
Gladkova ED; Nechepurenko IV; Bredikhin RA; Chepanova AA; Zakharenko AL; Luzina OA; Ilina ES; Dyrkheeva NS; Mamontova EM; Anarbaev RO; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998385
[TBL] [Abstract][Full Text] [Related]
3. SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivity.
Interthal H; Chen HJ; Kehl-Fie TE; Zotzmann J; Leppard JB; Champoux JJ
EMBO J; 2005 Jun; 24(12):2224-33. PubMed ID: 15920477
[TBL] [Abstract][Full Text] [Related]
4. New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan.
Khomenko TM; Zakharenko AL; Kornienko TE; Chepanova AA; Dyrkheeva NS; Artemova AO; Korchagina DV; Achara C; Curtis A; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298106
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors.
Zakharova O; Luzina O; Zakharenko A; Sokolov D; Filimonov A; Dyrkheeva N; Chepanova A; Ilina E; Ilyina A; Klabenkova K; Chelobanov B; Stetsenko D; Zafar A; Eurtivong C; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
Bioorg Med Chem; 2018 Aug; 26(15):4470-4480. PubMed ID: 30076000
[TBL] [Abstract][Full Text] [Related]
6. Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?
Hirano R; Interthal H; Huang C; Nakamura T; Deguchi K; Choi K; Bhattacharjee MB; Arimura K; Umehara F; Izumo S; Northrop JL; Salih MA; Inoue K; Armstrong DL; Champoux JJ; Takashima H; Boerkoel CF
EMBO J; 2007 Nov; 26(22):4732-43. PubMed ID: 17948061
[TBL] [Abstract][Full Text] [Related]
7. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.
Dexheimer TS; Antony S; Marchand C; Pommier Y
Anticancer Agents Med Chem; 2008 May; 8(4):381-9. PubMed ID: 18473723
[TBL] [Abstract][Full Text] [Related]
8. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy.
Takashima H; Boerkoel CF; John J; Saifi GM; Salih MA; Armstrong D; Mao Y; Quiocho FA; Roa BB; Nakagawa M; Stockton DW; Lupski JR
Nat Genet; 2002 Oct; 32(2):267-72. PubMed ID: 12244316
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Investigation of Novel Classes of 3-Carene-Derived Potent Inhibitors of TDP1.
Il'ina IV; Dyrkheeva NS; Zakharenko AL; Sidorenko AY; Li-Zhulanov NS; Korchagina DV; Chand R; Ayine-Tora DM; Chepanova AA; Zakharova OD; Ilina ES; Reynisson J; Malakhova AA; Medvedev SP; Zakian SM; Volcho KP; Salakhutdinov NF; Lavrik OI
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751997
[TBL] [Abstract][Full Text] [Related]
10. New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1.
Dyrkheeva NS; Filimonov AS; Luzina OA; Orlova KA; Chernyshova IA; Kornienko TE; Malakhova AA; Medvedev SP; Zakharenko AL; Ilina ES; Anarbaev RO; Naumenko KN; Klabenkova KV; Burakova EA; Stetsenko DA; Zakian SM; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768766
[TBL] [Abstract][Full Text] [Related]
11. Tyrosyl-DNA phosphodiesterase I catalytic mutants reveal an alternative nucleophile that can catalyze substrate cleavage.
Comeaux EQ; Cuya SM; Kojima K; Jafari N; Wanzeck KC; Mobley JA; Bjornsti MA; van Waardenburg RC
J Biol Chem; 2015 Mar; 290(10):6203-14. PubMed ID: 25609251
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer.
Hu DX; Tang WL; Zhang Y; Yang H; Wang W; Agama K; Pommier Y; An LK
J Med Chem; 2021 Jun; 64(11):7617-7629. PubMed ID: 34008967
[TBL] [Abstract][Full Text] [Related]
13. SCAN1-TDP1 trapping on mitochondrial DNA promotes mitochondrial dysfunction and mitophagy.
Ghosh A; Bhattacharjee S; Chowdhuri SP; Mallick A; Rehman I; Basu S; Das BB
Sci Adv; 2019 Nov; 5(11):eaax9778. PubMed ID: 31723605
[TBL] [Abstract][Full Text] [Related]
14. Deficiency in 3'-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1).
Zhou T; Lee JW; Tatavarthi H; Lupski JR; Valerie K; Povirk LF
Nucleic Acids Res; 2005; 33(1):289-97. PubMed ID: 15647511
[TBL] [Abstract][Full Text] [Related]
15. Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target.
Comeaux EQ; van Waardenburg RC
Drug Metab Rev; 2014 Nov; 46(4):494-507. PubMed ID: 25327705
[TBL] [Abstract][Full Text] [Related]
16. Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes.
Miao ZH; Agama K; Sordet O; Povirk L; Kohn KW; Pommier Y
DNA Repair (Amst); 2006 Dec; 5(12):1489-94. PubMed ID: 16935573
[TBL] [Abstract][Full Text] [Related]
17. Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors.
Ponomarev KY; Suslov EV; Zakharenko AL; Zakharova OD; Rogachev AD; Korchagina DV; Zafar A; Reynisson J; Nefedov AA; Volcho KP; Salakhutdinov NF; Lavrik OI
Bioorg Chem; 2018 Feb; 76():392-399. PubMed ID: 29248742
[TBL] [Abstract][Full Text] [Related]
18. Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
Salomatina OV; Popadyuk II; Zakharenko AL; Zakharova OD; Fadeev DS; Komarova NI; Reynisson J; Arabshahi HJ; Chand R; Volcho KP; Salakhutdinov NF; Lavrik OI
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562592
[TBL] [Abstract][Full Text] [Related]
19. Mutation of a conserved active site residue converts tyrosyl-DNA phosphodiesterase I into a DNA topoisomerase I-dependent poison.
He X; van Waardenburg RCAM; Babaoglu K; Price AC; Nitiss KC; Nitiss JL; Bjornsti MA; White SW
J Mol Biol; 2007 Sep; 372(4):1070-1081. PubMed ID: 17707402
[TBL] [Abstract][Full Text] [Related]
20. A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2
Li-Zhulanov NS; Zakharenko AL; Chepanova AA; Patel J; Zafar A; Volcho KP; Salakhutdinov NF; Reynisson J; Leung IKH; Lavrik OI
Molecules; 2018 Sep; 23(10):. PubMed ID: 30261631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
